Current therapeutic approaches in metastatic and recurrent Ewing Sarcoma

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Huang, Michael ^a   Lucas, Kenneth ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BUSULFAN; CARBOPLATIN; CIXUTUMUMAB; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MELPHALAN; PACLITAXEL; RAPAMYCIN; TEMOZOLOMIDE; THIOTEPA; TOPOTECAN; VINCRISTINE; ZOLEDRONIC ACID;

BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CANCER TRANSPLANTATION; CHILD; DRUG MEGADOSE; EWING SARCOMA; HUMAN; LOW DRUG DOSE; LUNG METASTASIS; METASTASIS; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; SOFT TISSUE METASTASIS; STEM CELL TRANSPLANTATION;

EID: 79251565814     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/863210     Document Type: Review

References (39)

1. Ries L., Smith M., Gurney J. G., Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 19751995 1999 National Cancer Institute
2. Rodriguez-Galindo C., Spunt S. L., Pappo A. S., Treatment of ewing sarcoma family of tumors: current status and outlook for the future Medical and Pediatric Oncology 2003 40 5 276 287
3. West D., Womer R., Study Progress Report on AEWS0031: Trial of Chemotherapy Intensification through Interval Compression in Ewing Sarcoma and Related Tumors 2007 Childrens Oncology Group
4. Cotterill S. J., Ahrens S., Paulussen M., Jurgens H. F., Voute P. A., Gadner H., Craft A. W., Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group Journal of Clinical Oncology 2000 18 17 3108 3114
5. Leavey P. J., Mascarenhas L., Marina N., Chen Z., Krailo M., Miser J., Brown K., Tarbell N., Bernstein M. L., Granowetter L., Gebhardt M., Grier H. E., Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the children's oncology group Pediatric Blood and Cancer 2008 51 3 334 338
6. Barker L. M., Pendergrass T. W., Sanders J. E., Hawkins D. S., Survival after recurrence of Ewing's sarcoma family of tumors Journal of Clinical Oncology 2005 23 19 4354 4362
7. Pinkerton C. R., Bataillard A., Guillo S., Oberlin O., Fervers B., Philip T., Treatment strategies for metastatic Ewing's sarcoma European Journal of Cancer 2001 37 11 1338 1344
8. Miser J. S., Goldsby R. E., Chen Z., Krailo M. D., Tarbell N. J., Link M. P., Fryer C. J. H., Pritchard D. J., Gebhardt M. C., Dickman P. S., Perlman E. J., Meyers P. A., Donaldson S. S., Moore S. G., Rausen A. R., Vietti T. J., Grier H. E., Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapya report from the Children's Oncology Group Pediatric Blood and Cancer 2007 49 7 894 900
9. Cangir A., Vietti T. J., Gehan E. A., Burgert E. O., Thomas P., Tefft M., Nesbit M. E., Kissane J., Pritchard D., Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two Intergroup Ewing's Sarcoma Studies Cancer 1990 66 5 887 893
10. Kushner B. H., Kramer K., Meyers P. A., Wollner N., Cheung N. K. V., Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors Medical and Pediatric Oncology 2000 35 5 468 474
11. Bernstein M. L., Devidas M., Lafreniere D., Souid A. K., Meyers P. A., Gebhardt M., Stine K., Nicholas R., Perlman E. J., Dubowy R., Wainer I. W., Dickman P. S., Link M. P., Goorin A., Grier H. E., Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: pediatric oncology group/children's cancer group phase II study 9457a report from the children's oncology group Journal of Clinical Oncology 2006 24 1 152 159
12. Paulussen M., Ahrens S., Craft A. W., Dunst J., Frhlich B., Jabar S., Rbe C., Winkelmann W., Wissing S., Zoubek A., Jörgens H., Ewing's tumors with primary lung metastases: survival analysis of 114 (European intergroup) cooperative Ewing's sarcoma studies patients Journal of Clinical Oncology 1998 16 9 3044 3052
13. Haeusler J., Ranft A., Boelling T., Gosheger G., Braun-Munzinger G., Vieth V., Burdach S., Van Den Berg H., Juergens H., Dirksen U., The value of local treatment in patients with primary, disseminated, multifocal ewing sarcoma (PDMES) Cancer 2010 116 2 443 450
14. Bernstein M., Kovar H., Paulussen M., Randall R. L., Schuck A., Teot L. A., Juergens H., Ewing's sarcoma family of tumors: current management The Oncologist 2006 11 5 503 519
15. Fraser C. J., Weigel B. J., Perentesis J. P., Dusenbery K. E., DeFor T. E., Baker K. S., Verneris M. R., Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors Bone Marrow Transplantation 2006 37 2 175 181
16. Kushner B. H., Meyers P. A., How effective is dose-intensive/ myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review Journal of Clinical Oncology 2001 19 3 870 880
17. Meyers P. A., Krailo M. D., Ladanyi M., Chan K. W., Sailer S. L., Dickman P. S., Baker D. L., Davis J. H., Gerbing R. B., Grovas A., Herzog C. E., Lindsley K. L., Liu-Mares W., Nachman J. B., Sieger L., Wadman J., Gorlick R. G., High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis Journal of Clinical Oncology 2001 19 11 2812 2820
18. Ladenstein R., Ptschger U., Le Deley M. C., Whelan J., Paulussen M., Oberlin O., van den Berg H., Dirksen U., Hjorth L., Michon J., Lewis I., Craft A., Jörgens H., Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial Journal of Clinical Oncology 2010 28 20 3284 3291
19. Mateo-Lozano S., Tirado O. M., Notario V., Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation Oncogene 2003 22 58 9282 9287
20. Lipskar A. M., Glick R. D., Huang J., Fisher J. C., DeVoti J., Pica R., Edelman M., Steinberg B. M., Soffer S. Z., Cyclooxygenase 2 mediates the antiangiogenic effect of rapamycin in Ewing sarcoma Journal of Pediatric Surgery 2009 44 6 1139 1147
21. Zhou Z., Guan H., Duan X., Kleinerman E. S., Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma Cancer 2005 104 8 1713 1720
22. Hunold A., Weddeling N., Paulussen M., Ranft A., Liebscher C., Jörgens H., Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors Pediatric Blood and Cancer 2006 47 6 795 800
23. Casey D. A., Wexler L. H., Merchant M. S., Chou A. J., Merola P. R., Price A. P., Meyers P. A., Irinotecan and temozolomide for Ewing sarcoma: the memorial sloan-kettering experience Pediatric Blood and Cancer 2009 53 6 1029 1034
24. Van Winkle P., Angiolillo A., Krailo M., Cheung Y. K., Anderson B., Davenport V., Reaman G., Cairo M. S., Ifosfamide, Carboplatin, and Etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience Pediatric Blood and Cancer 2005 44 4 338 347
25. Mora J., Cruz C. O., Parareda A., De Torres C., Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel Journal of Pediatric Hematology/Oncology 2009 31 10 723 729
26. Barker L. M., Pendergrass T. W., Sanders J. E., Hawkins D. S., Survival after recurrence of Ewing's sarcoma family of tumors Journal of Clinical Oncology 2005 23 19 4354 4362
27. Liu X. F., Helman L. J., Yeung C., Bera T. K., Lee B., Pastan I., XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma Cancer Research 2000 60 17 4752 4755
28. Perez-Martinez A., Leung W., Muoz E., Iyengar R., Ramrez M., Vicario J. L., Lassaletta.., Sevilla J., Gonzlez-Vicent M., Madero L., Daz-Pérez M.., KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors Pediatric Blood and Cancer 2009 53 1 120 124
29. Paulussen M., Ahrens S., Survival in primary disseminated or relapsed Ewing tumor-EICESS/CSS Medical and Pediatric Oncology 1996 24, article 237a
30. Burdach S., Van Kaick B., Laws H. J., Ahrens S., Haase R., Krholz D., Pape H., Dunst J., Kahn T., Willers R., Engel B., Dirksen U., Kramm C., Nrnberger W., Heyll A., Ladenstein R., Gadner H., Jörgens H., Gbel U., Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors: an update after long-term follow-up from two centers of the European intergroup study EICESS Annals of Oncology 2000 11 11 1451 1462
31. Lucas K. G., Schwartz C., Kaplan J., Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma Pediatric Blood and Cancer 2008 51 1 142 144
32. Toretsky J. A., Kalebic T., Blakesley V., LeRoith D., Helman L. J., The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts Journal of Biological Chemistry 1997 272 49 30822 30827
33. Cassier P., Pissaloux D., Alberti L., Ray-Coquard I., Blay J. Y., Targeted treatment of rare connective tissue tumors and sarcomas Bulletin du Cancer 2010 97 6 693 700
34. Pappo A. S., Patel S., Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients with recurrent or refractory Ewings sarcoma family of tumors (ESFT): results of a phase II SARC study Proceedings of the ASCO Annual Meeting 2010
35. Scotlandi K., Baldini N., Cerisano V., Manara M. C., Benini S., Serra M., Lollini P. L., Nanni P., Nicoletti G., Bernard G., Bernard A., Picci P., CD99 engagement: an effective therapeutic strategy for Ewing tumors Cancer Research 2000 60 18 5134 5142
36. Foell J. L., Hesse M., Volkmer I., Schmiedel B. J., Neumann I., Staege M. S., Membrane-associated phospholipase A1 beta (LIPI) is an Ewing tumour-associated cancer/testis antigen Pediatric Blood and Cancer 2008 51 2 228 234
37. Dagher R., Long L. M., Read E. J., Leitman S. F., Carter C. S., Tsokos M., Goletz T. J., Avila N., Berzofsky J. A., Helman L. J., Mackall C. L., Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study Medical and Pediatric Oncology 2002 38 3 158 164
38. Cho D., Shook D. R., Shimasaki N., Chang Y.-H., Fujisaki H., Campana D., Cytotoxicity of activated natural killer cells against pediatric solid tumors Clinical Cancer Research 2010 16 15 3901 3909
39. Verhoeven D. H. J., de Hooge A. S. K., Mooiman E. C. K., Santos S. J., ten Dam M. M., Gelderblom H., Melief C. J. M., Hogendoorn P. C. W., Egeler R. M., van Tol M. J. D., Schilham M. W., Lankester A. C., NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways Molecular Immunology 2008 45 15 3917 3925